FDA panel backs Daiichi's blood thinner

(Reuters) - A panel of advisers to the U.S. Food and Drug Administration voted 9-1 in favor of approving Japanese drugmaker Daiichi Sankyo Co's blood clot and stroke preventer for use in some patients with atrial fibrillation.

http://feedproxy.google.com/~r/reuters/healthNews/~3/UXCxq2J_rk0/story01.htm

Source: Reuters: Health - October 30, 2014 Category: Consumer Health News Tags: healthNews Source Type: news

More News: Atrial Fibrillation | Food and Drug Administration (FDA) | Health | Stroke